Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

*Product:*	Cabometyx
Active Ingredient:	Cabozantinib s-malate 25.34mg equivalent to cabozantinib 20mg
Dosage Form:	Film coated tablet
New Zealand Sponsor:	Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer:	Patheon Inc, Mississauga, Canada

*Product:*	Cabometyx
Active Ingredient:	Cabozantinib s-malate 50.69mg equivalent to cabozantinib 40mg
Dosage Form:	Film coated tablet
New Zealand Sponsor:	Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer:	Patheon Inc, Mississauga, Canada

*Product:*	Cabometyx
Active Ingredient:	Cabozantinib s-malate 76.03mg equivalent to cabozantinib 60mg
Dosage Form:	Film coated tablet
New Zealand Sponsor:	Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer:	Patheon Inc, Mississauga, Canada

*Product:*	Opdivo (40mg/4mL)
Active Ingredient:	Nivolumab 10mg/mL
Dosage Form:	Concentrate for infusion
New Zealand Sponsor:	Bristol-Myers Squibb (NZ) Limited
Manufacturers:	Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany Bristol-Myers Squibb Holdings Pharma Limited, Manati, Puerto Rico

*Product:*	Opdivo (100mg/10mL)
Active Ingredient:	Nivolumab 10mg/mL
Dosage Form:	Concentrate for infusion
New Zealand Sponsor:	Bristol-Myers Squibb (NZ) Limited
Manufacturers:	Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany Bristol-Myers Squibb Holdings Pharma Limited, Manati, Puerto Rico

*Product:*	PipTaz-AFT
Active Ingredients:	Piperacillin monohydrate 4000mg Tazobactam 500mg
Dosage Form:	Powder for injection
New Zealand Sponsor:	AFT Pharmaceuticals Limited
Manufacturer:	Shandong Anxin Pharmaceutical Co Limited, Jinan, China

*Product:*	Tecentriq
Active Ingredient:	Atezolizumab 840mg/14mL
Dosage Form:	Concentrate for infusion
New Zealand Sponsor:	Roche Products (NZ) Limited
Manufacturer:	F Hoffmann-La Roche Limited, Kaiseraugst, Switzerland

*Product:*	Tecentriq
Active Ingredient:	Atezolizumab 1200mg/20mL
Dosage Form:	Concentrate for infusion
New Zealand Sponsor:	Roche Products (NZ) Limited
Manufacturers:	Roche Diagnostics GmbH, Mannheim, Germany F Hoffmann-La Roche Limited, Kaiseraugst, Switzerland

Dated this 6th day of July 2022.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule